Paper9862371
Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.
Plebanski M and 10 others. Eur J Immunol, 1998. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. Papers, record 9862371. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9862371
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Protozoan | Major topic |
| Drug Delivery Systems | Major topic |
| Histocompatibility Antigens Class I | Major topic |
| Malaria | Major topic |
| Malaria Vaccines | Major topic |
| Plasmodium berghei | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cytotoxicity, Immunologic | |
| Humans | |
| Mice | |
| Recombinant Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02925403 | A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant | Background |
Source ClinicalTrials.gov
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42342712 | BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42342712 | PubMed |
| 36002507 | STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines. | Sci Rep | 2022 | https://conductscience.org/library/papers/36002507 | PubMed |
| 32153565 | Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. | Front Immunol | 2020 | https://conductscience.org/library/papers/32153565 | PubMed |
| 28779101 | Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria. | Sci Rep | 2017 | https://conductscience.org/library/papers/28779101 | PubMed |
| 28261200 | Vaccination with Altered Peptide Ligands of a Plasmodium berghei Circumsporozoite Protein CD8 T-Cell Epitope: A Model to Generate T Cells Resistant to Immune Interference by Polymorphic Epitopes. | Front Immunol | 2017 | https://conductscience.org/library/papers/28261200 | PubMed |
| 26590432 | The March Toward Malaria Vaccines. | Am J Prev Med | 2015 | https://conductscience.org/library/papers/26590432 | PubMed |
| 26350599 | Small Wonders-The Use of Nanoparticles for Delivering Antigen. | Vaccines (Basel) | 2015 | https://conductscience.org/library/papers/26350599 | PubMed |
| 26324116 | The march toward malaria vaccines. | Vaccine | 2015 | https://conductscience.org/library/papers/26324116 | PubMed |
| 25705207 | Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope. | Front Microbiol | 2015 | https://conductscience.org/library/papers/25705207 | PubMed |
| 25115805 | Depletion of regulatory T cells augments a vaccine-induced T effector cell response against the liver-stage of malaria but fails to increase memory. | PLoS One | 2014 | https://conductscience.org/library/papers/25115805 | PubMed |
| 23875044 | A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection. | PLoS Negl Trop Dis | 2013 | https://conductscience.org/library/papers/23875044 | PubMed |
| 23609325 | The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. | Sci Rep | 2013 | https://conductscience.org/library/papers/23609325 | PubMed |
| 22576456 | Immunotherapy of cancer in 2012. | CA Cancer J Clin | 2012 | https://conductscience.org/library/papers/22576456 | PubMed |
| 22348325 | Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice. | Malar J | 2012 | https://conductscience.org/library/papers/22348325 | PubMed |
| 22275401 | Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. | J Infect Dis | 2012 | https://conductscience.org/library/papers/22275401 | PubMed |
| 22044118 | T-cell-inducing vaccines - what's the future. | Immunology | 2012 | https://conductscience.org/library/papers/22044118 | PubMed |
| 17328786 | Mannan-mediated gene delivery for cancer immunotherapy. | Immunology | 2007 | https://conductscience.org/library/papers/17328786 | PubMed |
| 17067310 | Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide. | Immunology | 2006 | https://conductscience.org/library/papers/17067310 | PubMed |
| 16622207 | Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. | Infect Immun | 2006 | https://conductscience.org/library/papers/16622207 | PubMed |
| 15885121 | Building better T-cell-inducing malaria vaccines. | Immunology | 2005 | https://conductscience.org/library/papers/15885121 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9862371
GET https://conductscience.org/api/papers/v1/9862371/cited_by?page=2